Diagnostic and Laboratory Testing in Psychiatry |
From inside the book
Results 1-5 of 97
Page 1
Contents 1. Introduction and Overview 1 Mark S. Gold , M.D. , and A. L. C. Pottash
, M.D. 1. Introduction . 2. Terminology 3. Types of Procedures 4. Biopsychiatry
Today 5. Biopsychiatry Tomorrow 6. Testing as an Interim Measure 1 2 3 4 5 6 9
2.
Contents 1. Introduction and Overview 1 Mark S. Gold , M.D. , and A. L. C. Pottash
, M.D. 1. Introduction . 2. Terminology 3. Types of Procedures 4. Biopsychiatry
Today 5. Biopsychiatry Tomorrow 6. Testing as an Interim Measure 1 2 3 4 5 6 9
2.
Page 2
Mark S. Gold, A.L.C. Pottash. 14 15 15 . 6. Systematic Evaluation 6.1 . History ..
6.2 . Physical Examination 6.3 . Consultations .... 6.4 . Laboratory Testing 6.5 .
Neuroendocrine Testing 7. Evaluation of Drug - Abusing Patients 7.1 .
Mark S. Gold, A.L.C. Pottash. 14 15 15 . 6. Systematic Evaluation 6.1 . History ..
6.2 . Physical Examination 6.3 . Consultations .... 6.4 . Laboratory Testing 6.5 .
Neuroendocrine Testing 7. Evaluation of Drug - Abusing Patients 7.1 .
Page 3
Thyroid Testing in Psychiatric Patients Michael H. Kronig , M.D. , and Mark S.
Gold , M.D. 1. The Hypothalamic - pituitary - Thyroid Axis ... 2. Base - Line Thyroid
Testing 2.1 . Triiodothyronine , T4 , and Tz Resin Uptake 2.2 . Other Measures 2.3
.
Thyroid Testing in Psychiatric Patients Michael H. Kronig , M.D. , and Mark S.
Gold , M.D. 1. The Hypothalamic - pituitary - Thyroid Axis ... 2. Base - Line Thyroid
Testing 2.1 . Triiodothyronine , T4 , and Tz Resin Uptake 2.2 . Other Measures 2.3
.
Page 4
Mark S. Gold, A.L.C. Pottash. 6.1 . Testosterone 6.2 . Estrogen and Progesterone
7. Melatonin .... 7.1 . Regulation of Melatonin in the Central Nervous System 7.2 .
Seasonal Affective Disorder .... 7.3 . Serum Melatonin and Depression ...
Mark S. Gold, A.L.C. Pottash. 6.1 . Testosterone 6.2 . Estrogen and Progesterone
7. Melatonin .... 7.1 . Regulation of Melatonin in the Central Nervous System 7.2 .
Seasonal Affective Disorder .... 7.3 . Serum Melatonin and Depression ...
Page 5
Mark S. Gold, A.L.C. Pottash. 2. Amino Acids 3. Vitamins .... 4. Minerals ... 5.
Conclusion ... References 100 101 103 105 106 10. Central Nervous System
Neurodiagnostic Devices 107 William Hapworth , M.D. 1. Introduction .... 2.
Nuclear ...
Mark S. Gold, A.L.C. Pottash. 2. Amino Acids 3. Vitamins .... 4. Minerals ... 5.
Conclusion ... References 100 101 103 105 106 10. Central Nervous System
Neurodiagnostic Devices 107 William Hapworth , M.D. 1. Introduction .... 2.
Nuclear ...
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
I | 9 |
III | 9 |
IV | 9 |
V | 9 |
VI | 9 |
VII | 9 |
VIII | 9 |
IX | 10 |
CXXVII | 124 |
CXXVIII | 129 |
CXXX | 130 |
CXXXI | 131 |
CXXXIII | 132 |
CXXXIV | 134 |
CXXXV | 135 |
CXXXVI | 136 |
X | 11 |
XIII | 12 |
XVI | 13 |
XIX | 14 |
XXII | 15 |
XXVII | 16 |
XXIX | 17 |
XXX | 18 |
XXXI | 25 |
XXXIII | 26 |
XXXIV | 29 |
XXXVII | 30 |
XXXVIII | 36 |
XXXIX | 37 |
XL | 38 |
XLII | 39 |
XLIII | 40 |
XLV | 41 |
XLVI | 42 |
XLVII | 43 |
XLVIII | 45 |
L | 46 |
LI | 47 |
LIII | 48 |
LV | 49 |
LVI | 50 |
LVII | 51 |
LX | 53 |
LXII | 54 |
LXIII | 57 |
LXIV | 58 |
LXV | 59 |
LXVI | 60 |
LXVII | 61 |
LXVIII | 62 |
LXX | 63 |
LXXII | 64 |
LXXIII | 66 |
LXXV | 68 |
LXXVII | 69 |
LXXIX | 70 |
LXXXI | 71 |
LXXXII | 72 |
LXXXIII | 75 |
LXXXVI | 77 |
LXXXVII | 78 |
LXXXVIII | 79 |
LXXXIX | 80 |
XCI | 81 |
XCIII | 82 |
XCIV | 85 |
XCV | 86 |
XCVI | 87 |
XCVII | 88 |
XCIX | 90 |
CI | 91 |
CII | 92 |
CIII | 93 |
CIV | 97 |
CV | 98 |
CVI | 99 |
CVII | 101 |
CVIII | 103 |
CIX | 104 |
CX | 105 |
CXIII | 106 |
CXIV | 107 |
CXV | 108 |
CXVI | 109 |
CXVII | 110 |
CXIX | 111 |
CXX | 113 |
CXXI | 115 |
CXXII | 116 |
CXXIII | 120 |
CXXIV | 121 |
CXXV | 122 |
CXXVI | 123 |
CXXXVIII | 137 |
CXXXIX | 138 |
CXL | 139 |
CXLI | 140 |
CXLII | 141 |
CXLIII | 142 |
CXLIV | 143 |
CXLV | 144 |
CXLVI | 145 |
CXLVII | 147 |
CXLVIII | 148 |
CL | 149 |
CLI | 150 |
CLII | 153 |
CLIII | 154 |
CLIV | 155 |
CLVI | 156 |
CLVII | 157 |
CLVIII | 159 |
CLIX | 160 |
CLX | 161 |
CLXI | 162 |
CLXII | 164 |
CLXIII | 167 |
CLXIV | 169 |
CLXV | 171 |
CLXVI | 172 |
CLXVII | 174 |
CLXVIII | 177 |
CLXIX | 179 |
CLXX | 180 |
CLXXI | 183 |
CLXXII | 185 |
CLXXIV | 186 |
CLXXV | 189 |
CLXXVI | 193 |
CLXXVIII | 194 |
CLXXIX | 195 |
CLXXX | 196 |
CLXXXII | 197 |
CLXXXIII | 198 |
CLXXXV | 199 |
CLXXXVII | 200 |
CLXXXVIII | 201 |
CXC | 202 |
CXCI | 203 |
CXCIII | 204 |
CXCVI | 205 |
CXCVII | 208 |
CXCIX | 209 |
CC | 213 |
CCI | 218 |
CCII | 219 |
CCIII | 224 |
CCIV | 230 |
233 | |
CCVI | 235 |
CCVII | 237 |
CCVIII | 238 |
CCIX | 239 |
CCX | 240 |
CCXI | 242 |
CCXII | 243 |
247 | |
CCXIV | 249 |
CCXV | 250 |
CCXVI | 251 |
CCXVII | 252 |
CCXVIII | 253 |
CCXIX | 254 |
259 | |
CCXXI | 261 |
CCXXIII | 263 |
CCXXIV | 264 |
CCXXV | 266 |
CCXXVI | 267 |
269 | |
Common terms and phrases
abnormal abuse activity addition affective disorders alcohol antidepressant anxiety Arch Gen Psychiatry assessment associated behavior bipolar blood body brain cause central changes chronic Clin clinical complex concentration correlate cortisol criteria decreased deficiency dementia depressed patients detection determined dexamethasone diagnosis differential disease dose drug endogenous et al evaluation examination factors findings function glucose Gold growth half-life hormone Hospital hypothyroidism imaging important improve increased indicated laboratory lead levels lithium major depression mania measure mental metabolites MHPG mood neurological normal occur organic panic patterns physical physician plasma platelet positive possible present produce psychiatric psychosis psychotic recent relationship release reported response sample scales scan schizophrenia screen secretion seen sensitive serotonin serum severe signs specific stimulation studies substance suggested suppression symptoms syndrome Table thyroid tion treated treatment urine usually withdrawal York